70mg vial (BPC-157 10mg + GHK-Cu 50mg + TB500 10mg)
GLOW is a pre-mixed triple peptide blend combining BPC-157 (10mg), GHK-Cu (50mg) and TB500 (10mg) in a single 70mg vial. The blend is studied in research contexts for its complementary effects on collagen synthesis, dermal remodelling, angiogenesis, hair-follicle support and systemic soft-tissue recovery - bringing together a cytoprotective driver (BPC-157), a copper-binding transcriptomic modulator (GHK-Cu) and a systemic cell-migration regulator (TB500) in one reconstitution.
Checking availability…
BPC-157 upregulates the NO system, VEGF/EGF signalling and the FAK-paxillin pathway to accelerate fibroblast migration and local tissue repair. GHK-Cu acts as a tissue-damage signal that modulates over 4,000 genes, driving collagen I/III synthesis, antioxidant SOD activity and stem-cell chemoattraction. TB500 sequesters G-actin monomers to regulate actin polymerisation, supporting angiogenesis, systemic progenitor cell recruitment and dermal remodelling.
Common research protocols use 250–500mcg of the blend subcutaneously once daily, or split morning/evening, with administration adjacent to target areas (e.g. dermal or scalp regions) for localised effect. Cycles typically run 4–8 weeks on / 2–4 weeks off.
BPC-157 approx. 4 hours; GHK-Cu plasma approx. 0.5–1 hour with prolonged tissue activity; TB500 approx. 30–80 minutes with multi-day depot effect.
Reconstitute the 70mg vial with 2–3mL bacteriostatic water, injected slowly down the side of the vial. Swirl gently - do not shake. Solution will take on a faint blue-green tint from the copper complex; this is expected.
Lyophilised: 2–8°C, stable 18–24 months; avoid freeze-thaw cycles. Reconstituted: 2–8°C, protect from light, use within 30 days.
This site contains research-grade peptides information intended for laboratory use only. You must be at least 18 years of age to enter.
For research use only